Join
Live feed
·
PRReleasevia Quantisnow
Shattuck Labs Inc. logo

Shattuck Labs Announces Preliminary Clinical Data from Ongoing Phase 1 Clinical Trials of ARC Fusion Proteins SL-172154 and SL-279252

ByQuantisnow·Wall Street's wire, on your screen.
STTK· Shattuck Labs Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STTK (Shattuck Labs Inc.) and more on Quantisnow.